logo-loader
viewCollagen Solutions PLC

Investor results presentation

/**/ h2{margin-right:0cm;margin-left:0cm;font-size:18.0pt;font-family:"Times New Roman","serif";font-weight:bold;}h4{margin-top:2.0pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;line-height:107%;font-size:11.0pt;font-family:"Calibri Light","sans-serif";color:#2F5496;font-weight:normal;font-div:italic;}p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: #0563C1 }visited{ color: #954F72 } .av{size:612.0pt 792.0pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.av{}p.bw{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:15.0pt;line-height:normal}p.bx{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin: 0cm; margin-bottom: .0001pt; text-align: center}span.by{color: black; font-family: "Calibri","sans-serif"; font-size: 11.0pt; font-weight: bold}p.bz{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin: 0cm; margin-bottom: .0001pt; text-align: center}span.ca{font-size:11.0pt;font-family:"Calibri","sans-serif"; color:black}span.cb{font-size:11.0pt;font-family: "Calibri","sans-serif";color:black}p.cc{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold; margin: 0cm; margin-bottom: .0001pt}span.bp{font-size: 11.0pt;font-family:"Calibri","sans-serif";color:black} p.cd{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal}p.ce{margin-right:0cm;margin-left:0cm;font-size:11.0pt;font-family:"Calibri","sans-serif";margin:0cm;margin-bottom:.0001pt;text-align:justify; background:white}span.bm{color:black}table.cf{width:467.75pt;margin-left:-5.4pt;border-collapse:collapse}td.bj{width:225.9pt; padding:0cm 5.4pt 0cm 5.4pt}p.cg{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;font-weight: bold; line-height: normal; margin-bottom: 0cm}td.bh{width:220.25pt;padding:0cm 5.4pt 0cm 5.4pt}p.ch{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;margin-bottom:0cm;margin-bottom:.0001pt; line-height:normal}p.ci{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;line-height: normal; margin-bottom: 0cm; text-align: right}td.bf{width:187.65pt;padding:0cm 5.4pt 0cm 5.4pt} td.bc{width:258.5pt; padding:0cm 5.4pt 0cm 5.4pt}span.be{color:#0070C0;text-decoration: none}span.bd{color:#0070C0}td.bb{border:none}p.cj{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";text-align:justify}span.ck{font-family: "Calibri","sans-serif"; font-size: 11.0pt; font-weight: bold}p.cl{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";text-align:justify}span.cm{font-size:11.0pt;font-family:"Calibri","sans-serif"}span.aw{font-size:11.0pt; font-family:"Calibri","sans-serif"} /**/
RNS Number : 7953T
Collagen Solutions PLC
19 November 2019
 

19 November 2019

Collagen Solutions plc

("Collagen Solutions" or the "Company")

 

Investor results presentation

 

Collagen Solutions Plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces it will hold an investor results briefing on Tuesday, 3 December 2019.

 

The Company will announce its interim results for the six months ending 30 September 2019 on 3 December 2019 and will provide an update to investors that day. A briefing will take place at the Brand Exchange, 3 Birchin Lane, London EC3V 9BW at 4.30pm for a 4.45pm start.

 

Jamal Rushdy, CEO and Hilary Spence, CFO will give an overview of the results and the Company's future plans for growth. This will be followed by drinks and a chance to network.

 

To register, please call 020 7933 8780 or email [email protected].

 

Collagen Solutions Plc

 

Jamal Rushdy, CEO 

Via Walbrook

Hilary Spence, CFO

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or [email protected] 

Anna Dunphy

Mob: 07876 741 001

About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, tissue engineering, and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic®. The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

 For more information go to: www.collagensolutions.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NRAEVLFFKFFEFBX

Quick facts: Collagen Solutions PLC

Price: 3.4

Market: LSE
Market Cap: £15.09 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Collagen Solutions reports strong growth in its tissue business in first half

Collagen Solutions PLC's (LON:COS) Jamal Rushdy and Hilary Spence update Proactive London's Andrew Scott on first half performance - their third consecutive six-month period of double-digit sales growth. Revenues increased by 14% to £2.23mln in the period ended September 30. Tissue sales more...

on 3/12/19